RECENT NEWS
StreetInsider.com  Apr 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/CollabRx+%28CLRX%29+Enters+Molecular+Diagnostics+Partnership+with+Sengenics/8240416.html for the full story.
Cloud Computing  Oct 3  Comment 
CollabRx, Inc. (NASDAQ: CLRX) today announced a multi-year partnership agreement with Life Technologies Corporation for development and commercialization of CollabRx technology and content resources to be used in conjunction...
MarketWatch  Sep 27  Comment 
AutoGenomics files IPO papers that value firm at $65 million
Benzinga  Aug 29  Comment 
Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (NYSE: SNY), today announced that the New York State Department of Health has issued a license enabling Veracyte's...
Benzinga  Aug 29  Comment 
Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today announced that it has received a milestone payment from Ipsogen S.A., a subsidiary of the QIAGEN group.  This payment comes from a co-exclusive license...
Investment Underground » Page not found  Aug 22  Comment 
by Chris French In the past, medical professionals relied mostly on blood tests to determine the presence of life-threatening diseases and conditions in patients as blood contains small pieces of DNA, which clinicians extract from samples...
Benzinga  Jul 17  Comment 
Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (NYSE: SNY), today announced the publication of new data suggesting that routine clinical use of Veracyte's Afirma®...
Marketwire  Jul 11  Comment 
TUCSON, AZ -- (Marketwire) -- 07/11/12 -- HTG Molecular Diagnostics, a privately held, Tucson-based developer of mRNA and miRNA gene expression-based cancer diagnostics, has been granted a non-exclusive license to develop, manufacture, and
Benzinga  Jul 2  Comment 
Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic assays, announced that data from a study validating the Company's miRview® lung assay was published in the online edition of the Journal of...
Benzinga  Jun 25  Comment 
QIAGEN N.V. (NASDAQ: QGEN) today unveiled an advanced initiative to enter the field of next-generation sequencing (NGS) that aims to establish these technologies as routine processes used in new areas such as clinical research and molecular...




 

Molecular diagnostics is a new method of detecting a disease by analyzing a patient's DNA

Companies in the Molecular Diagnostics Industry (4)

  • M
  • Company icon
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki